Menu
GeneBe

rs12694937

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001111067.4(ACVR1):c.-7-1421A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0654 in 151,894 control chromosomes in the GnomAD database, including 669 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.065 ( 669 hom., cov: 31)

Consequence

ACVR1
NM_001111067.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.95
Variant links:
Genes affected
ACVR1 (HGNC:171): (activin A receptor type 1) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.165 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACVR1NM_001111067.4 linkuse as main transcriptc.-7-1421A>G intron_variant ENST00000434821.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACVR1ENST00000434821.7 linkuse as main transcriptc.-7-1421A>G intron_variant 1 NM_001111067.4 P4

Frequencies

GnomAD3 genomes
AF:
0.0653
AC:
9912
AN:
151776
Hom.:
666
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.168
Gnomad AMI
AF:
0.0768
Gnomad AMR
AF:
0.0395
Gnomad ASJ
AF:
0.0305
Gnomad EAS
AF:
0.0187
Gnomad SAS
AF:
0.0235
Gnomad FIN
AF:
0.0105
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0254
Gnomad OTH
AF:
0.0648
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0654
AC:
9933
AN:
151894
Hom.:
669
Cov.:
31
AF XY:
0.0627
AC XY:
4657
AN XY:
74238
show subpopulations
Gnomad4 AFR
AF:
0.168
Gnomad4 AMR
AF:
0.0395
Gnomad4 ASJ
AF:
0.0305
Gnomad4 EAS
AF:
0.0188
Gnomad4 SAS
AF:
0.0233
Gnomad4 FIN
AF:
0.0105
Gnomad4 NFE
AF:
0.0254
Gnomad4 OTH
AF:
0.0646
Alfa
AF:
0.0335
Hom.:
163
Bravo
AF:
0.0734
Asia WGS
AF:
0.0260
AC:
91
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
Cadd
Benign
12
Dann
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12694937; hg19: chr2-158657433; API